# New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

> **NCT01053390** · PHASE3 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 216 (actual)

## Conditions studied

- Gallbladder Neoplasms

## Interventions

- **DRUG:** Somatostatin
- **DRUG:** epirubicin, cisplatin, LV（Leucovorin）、 5-FU（5-Fluorouracil）

## Key facts

- **NCT ID:** NCT01053390
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2013-12-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053390, "New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01053390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*